#Clinical Trials

17 articles with this tag

Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
Artificial Intelligence

Sonomind Funding Fuels €3M Push for Novel Brain Stimulation

\n Paris-based Sonomind , a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).

6 months ago
Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
Funding Round

Sonomind Funding Fuels €3M Push for Novel Brain Stimulation

\n Paris-based Sonomind , a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).

6 months ago
Funding Round

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

7 months ago
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Funding Round

Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Zurich-based Mabylon , a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.

7 months ago
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Funding Round

Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.

7 months ago
Comphya Secures €8M Series A for ED Neurostimulation
Funding Round

Comphya Secures €8M Series A for ED Neurostimulation

\n Lausanne-based Comphya SA , a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.

9 months ago
Comphya Secures €8M Series A for ED Neurostimulation
Funding Round

Comphya Secures €8M Series A for ED Neurostimulation

\n Lausanne-based Comphya SA , a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.

9 months ago
CNBC Disruptor 50 on Formation Bio to Redefine Drug Development
Artificial Intelligence

CNBC Disruptor 50 on Formation Bio to Redefine Drug Development

9 months ago
Neuralink Secures Massive $650M Series E Funding
Funding Round

Neuralink Secures Massive $650M Series E Funding

10 months ago
Vivodyne Secures $40 Million to Revolutionize Drug Discovery
Funding Round

Vivodyne Secures $40 Million to Revolutionize Drug Discovery

10 months ago
Veltist Secures €160,000 in Funding for Innovative Surgical Patch
Funding Round

Veltist Secures €160,000 in Funding for Innovative Surgical Patch

Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.

10 months ago
Funding Round

Veltist Secures €160,000 in Funding for Innovative Surgical Patch

Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.

10 months ago
Press Release

MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry

10 months ago
Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes
Press Release

Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes

over 1 year ago
AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures
Startup News

AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures

almost 2 years ago
Accenture Ventures Backs QuantHealth, Clinical Trial Simulations
Startup News

Accenture Ventures Backs QuantHealth, Clinical Trial Simulations

about 2 years ago
PhaseV Nabs $15 Million Funding for ML Clinical Trial Optimization
Press Release

PhaseV Nabs $15 Million Funding for ML Clinical Trial Optimization

over 2 years ago